Bausch Health Companies Inc (BHC) Stock Price, Quote & News

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segm...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 514 744 6792

Website: www.bauschhealth.com

Address:

2150 St. ElzEar Boulevard West, Laval, Canada

Sciguy67 Jan. 20 at 10:53 PM

$BHC if Red C is a bust then back to the $4

1 · Reply

FU2 Jan. 20 at 6:38 PM

$BHC my favorite POS. Never never disappoints. I guess we just sink for 2 weeks till some Red-C news, and that might not even help with the manipulation here. Could see $5.95 again..

0 · Reply

btradingwarehouse Jan. 20 at 3:52 PM

$BHC ...2BULLS... Champs beaten down Warriors I tried to prepare you for this It took me some years to get what's behind this I posted about that ... Now allow me to focus you on another thing You will notice that sudden surge of non-sense posts with bearish smell usually presented as "hesitant bullS realizing how wrong she/he was about BHC" IGNORE THAT BULLSHIT !!! Those are pitiful small props (up to $1-5 mil) that took short side; even 2-3 individuals got short and trying to influence matter ... What matter is this: Long time losers (myself included) will have to wait much longer to get some relief Read my previous posts (not so bs as you could expect) ... Conclusion: YOU ARE NOT SELLING THIS !!! DO NOT START AVERAGING YET !!! MONITOR BLCO ($21+) Stay smart strong smile

1 · Reply

Nemo1402 Jan. 20 at 3:14 PM

$BHC 😎

0 · Reply

Nemo1402 Jan. 20 at 6:17 AM

$BHC - market down so it will be go more down too 🤷‍♂️

0 · Reply

mrboeing Jan. 20 at 2:53 AM

$BHC F this company and it's sorry existence. F this company. Stinky garbage @ss company.

0 · Reply

PnLBotTrack_979 Jan. 19 at 8:21 PM

$BHC Legacy pharma rerate story, moves on debt and regulatory catalysts

0 · Reply

mrboeing Jan. 19 at 4:34 PM

$BHC A filthy trash POS garbage can. Filled with stinky diapers and nothing but sorry stories.

0 · Reply

Nemo1402 Jan. 19 at 9:26 AM

$BHC

0 · Reply

mrboeing Jan. 19 at 1:34 AM

$BHC A filthy trash, garbage junk company. Its been 10 yrs and has only gone down.

0 · Reply

Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026

Jan 15, 2026, 3:15 AM EST - 6 days ago

Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 5, 2026, 7:00 AM EST - 16 days ago

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 23, 2025, 5:35 PM EST - 4 weeks ago

Bausch Health Announces Final Results and Expiration of Exchange Offers

Dec 8, 2025, 7:22 PM EST - 6 weeks ago

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

Dec 2, 2025, 12:43 PM EST - 7 weeks ago

Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 1, 2025, 7:00 AM EST - 7 weeks ago

Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China

Nov 24, 2025, 7:05 AM EST - 2 months ago

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

Nov 18, 2025, 7:00 AM EST - 2 months ago

Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference

Nov 13, 2025, 8:18 AM EST - 2 months ago

Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical

Nov 13, 2025, 7:00 AM EST - 2 months ago

Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day

Nov 11, 2025, 7:07 AM EST - 2 months ago

Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path

Nov 5, 2025, 8:00 AM EST - 2 months ago

Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Nov 3, 2025, 4:30 PM EST - 2 months ago

Bausch + Lomb to Hold Investor Day on Nov. 13

Oct 31, 2025, 7:45 AM EDT - 2 months ago

Why Bausch Health Is A Buy After Rising 10% On Third-Quarter Results

Oct 29, 2025, 8:26 PM EDT - 2 months ago

Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:05 PM EDT - 2 months ago

Bausch Health Announces Third Quarter 2025 Results

Oct 20, 2025, 10:57 AM EDT - 3 months ago

Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb

Oct 9, 2025, 7:00 AM EDT - 3 months ago

Bausch Health Announces Results of Special Meeting of Shareholders

Sep 30, 2025, 8:00 AM EDT - 4 months ago

Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV

Sep 30, 2025, 7:00 AM EDT - 4 months ago

Bausch Health to Announce Third Quarter 2025 Results on October 29

Sep 29, 2025, 8:00 AM EDT - 4 months ago

Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

Sep 11, 2025, 12:04 PM EDT - 4 months ago

Bausch Health: Repricing Continues As Deleveraging Gains Traction

Sep 11, 2025, 8:35 AM EDT - 4 months ago

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

Sep 11, 2025, 7:00 AM EDT - 4 months ago

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

Sep 9, 2025, 7:00 AM EDT - 4 months ago

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

Sep 5, 2025, 8:02 AM EDT - 4 months ago

Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System

Aug 26, 2025, 8:00 AM EDT - 5 months ago

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

DRRX

Aug 21, 2025, 8:02 AM EDT - 5 months ago

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan

Aug 18, 2025, 5:48 PM EDT - 5 months ago

Bausch + Lomb board members resign after Icahn agreement ends

Aug 15, 2025, 2:30 PM EDT - 5 months ago

Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes

Aug 12, 2025, 1:02 PM EDT - 5 months ago

Why Bausch Health Stock Surged By Nearly 20%

Aug 7, 2025, 8:00 AM EDT - 5 months ago

Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners

Jul 30, 2025, 11:30 PM EDT - 6 months ago

Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 4:05 PM EDT - 6 months ago

Bausch Health Announces Second Quarter 2025 Results

Jul 29, 2025, 2:21 PM EDT - 6 months ago

Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout

DRRX

Jul 29, 2025, 7:00 AM EDT - 6 months ago

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

DRRX

Jul 29, 2025, 7:00 AM EDT - 6 months ago

Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops

Jul 28, 2025, 9:10 AM EDT - 6 months ago

Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand

Jul 24, 2025, 8:02 AM EDT - 6 months ago

Bausch Health Announces the Appointment of Two New Members to Its Board of Directors

Jul 10, 2025, 5:00 PM EDT - 6 months ago

CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs

Jul 10, 2025, 4:15 PM EDT - 6 months ago

Bausch Health Appoints New Chief Accounting Officer

Jul 9, 2025, 8:00 AM EDT - 7 months ago

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs

Jul 7, 2025, 8:00 AM EDT - 7 months ago

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence

Jul 2, 2025, 7:00 AM EDT - 7 months ago

Bausch Health to Announce Second Quarter 2025 Results on July 30

Jun 26, 2025, 4:30 PM EDT - 7 months ago

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

Jun 22, 2025, 5:00 AM EDT - 7 months ago

A Billionaire Trump Supporter Is Buying These Two Stocks

PPTA

Jun 18, 2025, 11:01 AM EDT - 7 months ago

Bausch Health Shares Rise as Nonexecutive Chairperson Paulson Buys $21.2M in Shares

Jun 16, 2025, 4:04 AM EDT - 7 months ago

Repricing Potential Driven By Deleveraging

Jun 4, 2025, 6:59 AM EDT - 8 months ago

Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States

Sciguy67 Jan. 20 at 10:53 PM

$BHC if Red C is a bust then back to the $4

1 · Reply

FU2 Jan. 20 at 6:38 PM

$BHC my favorite POS. Never never disappoints. I guess we just sink for 2 weeks till some Red-C news, and that might not even help with the manipulation here. Could see $5.95 again..

0 · Reply

btradingwarehouse Jan. 20 at 3:52 PM

1 · Reply

Nemo1402 Jan. 20 at 3:14 PM

$BHC 😎

0 · Reply

Nemo1402 Jan. 20 at 6:17 AM

$BHC - market down so it will be go more down too 🤷‍♂️

0 · Reply

mrboeing Jan. 20 at 2:53 AM

$BHC F this company and it's sorry existence. F this company. Stinky garbage @ss company.

0 · Reply

PnLBotTrack_979 Jan. 19 at 8:21 PM

$BHC Legacy pharma rerate story, moves on debt and regulatory catalysts

0 · Reply

mrboeing Jan. 19 at 4:34 PM

$BHC A filthy trash POS garbage can. Filled with stinky diapers and nothing but sorry stories.

0 · Reply

Nemo1402 Jan. 19 at 9:26 AM

$BHC

0 · Reply

mrboeing Jan. 19 at 1:34 AM

$BHC A filthy trash, garbage junk company. Its been 10 yrs and has only gone down.

0 · Reply

BioTechHealthX Jan. 18 at 4:49 PM

$BHC Despite stable cash flow and restructuring efforts, Bausch Health (NYSE:BHC) continues to trade at distressed levels, reflecting lingering doubts about durability and growth. https://biotechhealthx.com/biotech-news/why-bausch-health-bhc-keeps-trading-like-a-problem-not-a-comeback/

0 · Reply

mrboeing Jan. 18 at 3:49 PM

$BHC Bauch Health, a trash can filled w/ smelly diapers, old expired food, and other household trash.

0 · Reply

mrboeing Jan. 17 at 6:37 PM

$BHC Filthy garbage can

0 · Reply

mrboeing Jan. 17 at 4:47 AM

$BHC Garbage company with nothing but sorry stories. Going to $0.

0 · Reply

Arcides Jan. 17 at 1:26 AM

$BHC all YTD gains gone..

0 · Reply

mrboeing Jan. 17 at 1:09 AM

$BHC what a filthy, garbage, sad POS company. F this company, filthy garbage can that will never return anything to shareholders. Will go to 0

0 · Reply

Rpate Jan. 16 at 8:33 PM

$BHC Jp Morgan conference was disaster. CEO proved himself is depressed.

2 · Reply

Arcides Jan. 16 at 6:32 PM

$BHC popped strong the first 4 days of this year, but it has given back almos all gains ytd, not what you wanna see.

0 · Reply

FU2 Jan. 16 at 2:09 PM

$BHC today might be the last chance to buy in the $6's. See how they play it out.

0 · Reply

Broview Jan. 15 at 4:32 PM

$BHC PS insanely low? Undervalued much?

0 · Reply

COEG Jan. 15 at 8:15 AM

$BHC Strong BHC presentation at JPM Healthcare conference. Focusing BHC ex BLCO only. Looks like a pitch deck. Looking forward to Q4/2025 figures and outlook 2026.

1 · Reply

SellSalix Jan. 14 at 6:10 PM

$BHC if they release early findings of their stage 3 trial (ie Red-C) and it’s positive, this POS may just go ape shit for once…

1 · Reply

Market Cap	2.59B
Revenue (ttm)	9.63B
Net Income (ttm)	-46.00M
EPS (ttm)	N/A
PE Ratio	1.91
Forward PE	1.71
Profit Margin	-0.48%
Debt to Equity Ratio	59.11

Volume	1,976,300
Avg Vol	2,452,522
Day's Range	N/A - N/A
Shares Out	370.87M
Stochastic %K	6%
Beta	0.37
Analysts	Hold
Price Target	$7.43